Cargando…
Knockdown of CENPK inhibits cell growth and facilitates apoptosis via PTEN‐PI3K‐AKT signalling pathway in gastric cancer
Previous studies have indicated that centromere protein K (CENPK) is upregulated in several cancers and related to tumorigenesis. Nevertheless, the potential function of CENPK in gastric cancer (GC) remains unknown. Here, we investigated the function of CENPK on oncogenicity and explored its underly...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435434/ https://www.ncbi.nlm.nih.gov/pubmed/34382342 http://dx.doi.org/10.1111/jcmm.16850 |
_version_ | 1783751791948595200 |
---|---|
author | Wu, Shusheng Cao, Lulu Ke, Lihong Yan, Ying Luo, Huiqin Hu, Xiaoxiu Niu, Jiayu Li, Huimin Xu, Huijun Chen, Wenju Pan, Yueyin He, Yifu |
author_facet | Wu, Shusheng Cao, Lulu Ke, Lihong Yan, Ying Luo, Huiqin Hu, Xiaoxiu Niu, Jiayu Li, Huimin Xu, Huijun Chen, Wenju Pan, Yueyin He, Yifu |
author_sort | Wu, Shusheng |
collection | PubMed |
description | Previous studies have indicated that centromere protein K (CENPK) is upregulated in several cancers and related to tumorigenesis. Nevertheless, the potential function of CENPK in gastric cancer (GC) remains unknown. Here, we investigated the function of CENPK on oncogenicity and explored its underlying mechanisms in GC. Our results showed that CENPK was dramatically overexpressed in GC and was associated with poor prognosis through bioinformatics analysis. We demonstrated that CENPK is upregulated in GC tissues and cell lines. Moreover, knockdown of CENPK significantly inhibited proliferation in vitro and attenuated the growth of implanted GCs in vivo. In addition, CENPK silencing induced G1 phase cell cycle arrest and facilitated apoptosis of GC cells. KEGG pathway analysis indicated that the PI3K‐AKT signalling pathway was considerably enriched. Knockdown of CENPK decreased the expression of PI3K, p‐Akt (Ser437) and p‐GSK3β (Ser9) in GC cells, and increased the expression of PTEN. In conclusion, this study indicated that CENPK was overexpressed in GC and may promote gastric carcinogenesis through the PTEN‐PI3K‐AKT signalling pathway. Thus, CENPK may be a potential target for cancer therapeutics in GC. |
format | Online Article Text |
id | pubmed-8435434 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84354342021-09-15 Knockdown of CENPK inhibits cell growth and facilitates apoptosis via PTEN‐PI3K‐AKT signalling pathway in gastric cancer Wu, Shusheng Cao, Lulu Ke, Lihong Yan, Ying Luo, Huiqin Hu, Xiaoxiu Niu, Jiayu Li, Huimin Xu, Huijun Chen, Wenju Pan, Yueyin He, Yifu J Cell Mol Med Original Articles Previous studies have indicated that centromere protein K (CENPK) is upregulated in several cancers and related to tumorigenesis. Nevertheless, the potential function of CENPK in gastric cancer (GC) remains unknown. Here, we investigated the function of CENPK on oncogenicity and explored its underlying mechanisms in GC. Our results showed that CENPK was dramatically overexpressed in GC and was associated with poor prognosis through bioinformatics analysis. We demonstrated that CENPK is upregulated in GC tissues and cell lines. Moreover, knockdown of CENPK significantly inhibited proliferation in vitro and attenuated the growth of implanted GCs in vivo. In addition, CENPK silencing induced G1 phase cell cycle arrest and facilitated apoptosis of GC cells. KEGG pathway analysis indicated that the PI3K‐AKT signalling pathway was considerably enriched. Knockdown of CENPK decreased the expression of PI3K, p‐Akt (Ser437) and p‐GSK3β (Ser9) in GC cells, and increased the expression of PTEN. In conclusion, this study indicated that CENPK was overexpressed in GC and may promote gastric carcinogenesis through the PTEN‐PI3K‐AKT signalling pathway. Thus, CENPK may be a potential target for cancer therapeutics in GC. John Wiley and Sons Inc. 2021-08-12 2021-09 /pmc/articles/PMC8435434/ /pubmed/34382342 http://dx.doi.org/10.1111/jcmm.16850 Text en © 2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Wu, Shusheng Cao, Lulu Ke, Lihong Yan, Ying Luo, Huiqin Hu, Xiaoxiu Niu, Jiayu Li, Huimin Xu, Huijun Chen, Wenju Pan, Yueyin He, Yifu Knockdown of CENPK inhibits cell growth and facilitates apoptosis via PTEN‐PI3K‐AKT signalling pathway in gastric cancer |
title | Knockdown of CENPK inhibits cell growth and facilitates apoptosis via PTEN‐PI3K‐AKT signalling pathway in gastric cancer |
title_full | Knockdown of CENPK inhibits cell growth and facilitates apoptosis via PTEN‐PI3K‐AKT signalling pathway in gastric cancer |
title_fullStr | Knockdown of CENPK inhibits cell growth and facilitates apoptosis via PTEN‐PI3K‐AKT signalling pathway in gastric cancer |
title_full_unstemmed | Knockdown of CENPK inhibits cell growth and facilitates apoptosis via PTEN‐PI3K‐AKT signalling pathway in gastric cancer |
title_short | Knockdown of CENPK inhibits cell growth and facilitates apoptosis via PTEN‐PI3K‐AKT signalling pathway in gastric cancer |
title_sort | knockdown of cenpk inhibits cell growth and facilitates apoptosis via pten‐pi3k‐akt signalling pathway in gastric cancer |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435434/ https://www.ncbi.nlm.nih.gov/pubmed/34382342 http://dx.doi.org/10.1111/jcmm.16850 |
work_keys_str_mv | AT wushusheng knockdownofcenpkinhibitscellgrowthandfacilitatesapoptosisviaptenpi3kaktsignallingpathwayingastriccancer AT caolulu knockdownofcenpkinhibitscellgrowthandfacilitatesapoptosisviaptenpi3kaktsignallingpathwayingastriccancer AT kelihong knockdownofcenpkinhibitscellgrowthandfacilitatesapoptosisviaptenpi3kaktsignallingpathwayingastriccancer AT yanying knockdownofcenpkinhibitscellgrowthandfacilitatesapoptosisviaptenpi3kaktsignallingpathwayingastriccancer AT luohuiqin knockdownofcenpkinhibitscellgrowthandfacilitatesapoptosisviaptenpi3kaktsignallingpathwayingastriccancer AT huxiaoxiu knockdownofcenpkinhibitscellgrowthandfacilitatesapoptosisviaptenpi3kaktsignallingpathwayingastriccancer AT niujiayu knockdownofcenpkinhibitscellgrowthandfacilitatesapoptosisviaptenpi3kaktsignallingpathwayingastriccancer AT lihuimin knockdownofcenpkinhibitscellgrowthandfacilitatesapoptosisviaptenpi3kaktsignallingpathwayingastriccancer AT xuhuijun knockdownofcenpkinhibitscellgrowthandfacilitatesapoptosisviaptenpi3kaktsignallingpathwayingastriccancer AT chenwenju knockdownofcenpkinhibitscellgrowthandfacilitatesapoptosisviaptenpi3kaktsignallingpathwayingastriccancer AT panyueyin knockdownofcenpkinhibitscellgrowthandfacilitatesapoptosisviaptenpi3kaktsignallingpathwayingastriccancer AT heyifu knockdownofcenpkinhibitscellgrowthandfacilitatesapoptosisviaptenpi3kaktsignallingpathwayingastriccancer |